Express Pharma

AstraZeneca’s Durvalumab gets CDSCO nod to treat locally advanced or metastatic biliary tract cancer

The approval for AstraZeneca molecule is based on the findings of TOPAZ-1, a Phase-3 global clinical trial with patients recruited from India as well, that evaluated immunotherapy plus chemotherapy as first line treatment for advanced BTCs